In the news
See all news
September 01, 2017
Inventive medical device company granted GCT a many-sided task of diversified consulting and comprehensive regulatory support in obtaining license for their revolutionary product to be marketed in Russia.
August 31, 2017
Phase III multi-center double-blind anaesthesiology study outsourced to GCT by a leading Russian pharmaceutical company gets off the ground within the projected timelines.
Following screening procedures and randomization, first subject successfully underwent a complicated abdominal surgery, with the use of an inhalational anesthesia this Monday. Patient feels well now, and GCT team was happy to contribute to his fast recovery.
The study is being conducted at two investigative sites in Russia each aiming to enroll 60 subjects within the aggressive timelines.
July 28, 2017
GCT local office in Mumbai operating under the name “GCT Pharma Research (India) Pvt Ltd” (GCT-India for short) will assist global pharmaceutical companies in performing clinical trials in India. GCT-India will also support the local biopharma community willing to conduct clinical research within CEE countries and Russia, thus helping them to market their products in that attractive region.